基础研究
Copyright ©The Author(s) 2008.
世界华人消化杂志. 2008-04-08; 16(10): 1053-1058
在线出版 2008-04-08. doi: 10.11569/wcjd.v16.i10.1053
表1 各组肝功能变化(mean±SD)
分组nALT(nkat/L)TBIL(μmol/L)
Sham组8213±1.397.25±0.48
CBDL 3 wk81915±22.64a423.34±43.31a
4 wk72629±29.72a496.30±54.45a
5 wk73569±26.34a612.57±66.67a
表2 各组血浆和肝、肺组织中ET-1水平变化 (mean±SD, ng/L)
分组n血浆ET-1肝组织ET-1肺组织ET-1
Sham组849.42±2.7343.87±5.72263.21±6.21
CBDL 3 wk871.91±4.21a154.65±4.99a344.65±13.15
4 wk782.83±8.32a213.44±13.13a372.36±21.08
5 wk7103.61±6.06a254.66±13.89a434.37±12.76a
表3 各组血清和肝、肺组织中NO水平动态变化 (mean±SD)
分组n血清NO(μmol/L)肝组织NO(μmol/g)肺组织NO(μmol/g)
Sham组837.70±10.534.42±0.555.45±0.50
CBDL 3 wk8137.14±25.02a7.68±0.51a7.90±0.35a
4 wk7174.67±26.88a8.99±0.65a9.14±0.56a
5 wk7203.83±19.08a10.97±0.95a10.38±0.96a
表4 各组血浆和肝、肺组织中CGRP水平动态变化 (mean±SD, ng/L)
分组n血浆CGRP肝组织CGRP肺组织CGRP
Sham组844.37±9.01184.23±28.69176.26±19.57
CBDL 3 wk880.70±8.37a362.07±37.82a276.68±27.34a
4 wk7113.60±25.79a595.34±60.83a361.84±33.83a
5 wk7159.61±17.85a908.84±101.33a526.79±41.66a
表5 ALT与各阶段血浆和肝、肺组织匀浆中ET-1, NO, CGRP水平rP值比较
ALTET-1
NO
CGRP
rPrPrP
血浆0.98890.0111a0.99350.0065a0.97140.0286a
肝组织0.99690.0035a0.99930.0070a0.95070.0493a
肺组织0.99390.0061a0.99910.0009a0.95570.0443a
表6 TBIL与各阶段血浆和肝、肺组织匀浆中ET-1, NO, CGRP水平rP值比较
TBILET-1
NO
CGRP
rPrPrP
血浆0.94850.05150.98630.0130a0.94850.0515
肝组织0.98210.0173a0.97720.0228a0.98210.0173a
肺组织0.96450.0355a0.97800.0215a0.96450.0355a

引文著录: 颜玉, 鲍秀琦, 王艳, 遇常红, 韩桂华, 姜威. 血管活性物质在大鼠肝肺综合征发病机制中的作用. 世界华人消化杂志 2008; 16(10): 1053-1058